223 related articles for article (PubMed ID: 23670570)
21. Local progression after radiofrequency ablation for pulmonary metastases.
von Meyenfeldt EM; Prevoo W; Peyrot D; Lai A Fat N; Burgers SJ; Wouters MW; Klomp HM
Cancer; 2011 Aug; 117(16):3781-7. PubMed ID: 21319158
[TBL] [Abstract][Full Text] [Related]
22. Long-term results of percutaneous radiofrequency ablation of pulmonary metastases: a single institution experience.
Fanucchi O; Ambrogi MC; Aprile V; Cioni R; Cappelli C; Melfi F; Massimetti G; Mussi A
Interact Cardiovasc Thorac Surg; 2016 Jul; 23(1):57-64. PubMed ID: 27059068
[TBL] [Abstract][Full Text] [Related]
23. Percutaneous radiofrequency ablation of liver metastases in potential candidates for resection: the "test-of-time approach".
Livraghi T; Solbiati L; Meloni F; Ierace T; Goldberg SN; Gazelle GS
Cancer; 2003 Jun; 97(12):3027-35. PubMed ID: 12784338
[TBL] [Abstract][Full Text] [Related]
24. Pulmonary radiofrequency ablation: long-term safety and efficacy in 153 patients.
Simon CJ; Dupuy DE; DiPetrillo TA; Safran HP; Grieco CA; Ng T; Mayo-Smith WW
Radiology; 2007 Apr; 243(1):268-75. PubMed ID: 17392258
[TBL] [Abstract][Full Text] [Related]
25. Radiofrequency ablation of pulmonary metastases from sarcoma: single-center retrospective evaluation of 46 patients.
Sato T; Iguchi T; Hiraki T; Gobara H; Fujiwara H; Sakurai J; Matsui Y; Mitsuhashi T; Soh J; Toyooka S; Kanazawa S
Jpn J Radiol; 2017 Feb; 35(2):61-67. PubMed ID: 27864664
[TBL] [Abstract][Full Text] [Related]
26. Stereotactic body radiation therapy for lung metastases from soft tissue sarcoma.
Navarria P; Ascolese AM; Cozzi L; Tomatis S; D'Agostino GR; De Rose F; De Sanctis R; Marrari A; Santoro A; Fogliata A; Cariboni U; Alloisio M; Quagliuolo V; Scorsetti M
Eur J Cancer; 2015 Mar; 51(5):668-74. PubMed ID: 25686482
[TBL] [Abstract][Full Text] [Related]
27. Radiofrequency ablation is a valid treatment option for lung metastases: experience in 566 patients with 1037 metastases.
de Baère T; Aupérin A; Deschamps F; Chevallier P; Gaubert Y; Boige V; Fonck M; Escudier B; Palussiére J
Ann Oncol; 2015 May; 26(5):987-991. PubMed ID: 25688058
[TBL] [Abstract][Full Text] [Related]
28. Extending indications for radiofrequency ablation of lung tumors through an intraoperative approach.
Linden PA; Wee JO; Jaklitsch MT; Colson YL
Ann Thorac Surg; 2008 Feb; 85(2):420-3. PubMed ID: 18222236
[TBL] [Abstract][Full Text] [Related]
29. [Radiofrequency ablation (RFA) of lung metastases from colorectal cancer (CRC)-one-year follow-up].
Steinke K; King J; Glenn D; Morris DL
Radiologe; 2004 Jul; 44(7):687-92. PubMed ID: 15232689
[TBL] [Abstract][Full Text] [Related]
30. Small liver colorectal metastases treated with percutaneous radiofrequency ablation: local response rate and long-term survival with up to 10-year follow-up.
Solbiati L; Ahmed M; Cova L; Ierace T; Brioschi M; Goldberg SN
Radiology; 2012 Dec; 265(3):958-68. PubMed ID: 23091175
[TBL] [Abstract][Full Text] [Related]
31. Percutaneous radiofrequency thermal ablation in the management of lung tumors: presentation of clinical experience on a series of 35 patients.
Thanos L; Mylona S; Ptohis N; Tsiouris S; Sotiropoulou E; Pomoni A; Pomoni M
Diagn Interv Radiol; 2009 Dec; 15(4):290-6. PubMed ID: 19813168
[TBL] [Abstract][Full Text] [Related]
32. Primary non-small cell lung cancer: review of frequency, location, and time of recurrence after radiofrequency ablation.
Beland MD; Wasser EJ; Mayo-Smith WW; Dupuy DE
Radiology; 2010 Jan; 254(1):301-7. PubMed ID: 20032160
[TBL] [Abstract][Full Text] [Related]
33. Cancer-free survival and local tumor control after impendence-based radiofrequency ablation of biopsy-proven renal cell carcinomas with a minimum of 1-year follow-up.
Forauer AR; Dewey BJ; Seigne JD
Urol Oncol; 2014 Aug; 32(6):869-76. PubMed ID: 24946958
[TBL] [Abstract][Full Text] [Related]
34. Radiographic Local Tumor Control and Pain Palliation of Sarcoma Metastases within the Musculoskeletal System with Percutaneous Thermal Ablation.
Vaswani D; Wallace AN; Eiswirth PS; Madaelil TP; Chang RO; Tomasian A; Jennings JW
Cardiovasc Intervent Radiol; 2018 Aug; 41(8):1223-1232. PubMed ID: 29541840
[TBL] [Abstract][Full Text] [Related]
35. Factors associated with actual long-term survival following soft tissue sarcoma pulmonary metastasectomy.
Smith R; Pak Y; Kraybill W; Kane JM
Eur J Surg Oncol; 2009 Apr; 35(4):356-61. PubMed ID: 18294807
[TBL] [Abstract][Full Text] [Related]
36. Risk factors for occurrence of local tumor progression after percutaneous radiofrequency ablation for lung neoplasms.
Yamagami T; Kato T; Hirota T; Yoshimatsu R; Matsumoto T; Shimada J; Nishimura T
Diagn Interv Radiol; 2007 Dec; 13(4):199-203. PubMed ID: 18092293
[TBL] [Abstract][Full Text] [Related]
37. Percutaneous radiofrequency ablation of lung cancer presenting as ground-glass opacity.
Iguchi T; Hiraki T; Gobara H; Fujiwara H; Matsui Y; Soh J; Toyooka S; Kiura K; Kanazawa S
Cardiovasc Intervent Radiol; 2015 Apr; 38(2):409-15. PubMed ID: 24938905
[TBL] [Abstract][Full Text] [Related]
38. Five-year survival following radiofrequency ablation of small, solitary, hepatic colorectal metastases.
Gillams AR; Lees WR
J Vasc Interv Radiol; 2008 May; 19(5):712-7. PubMed ID: 18440460
[TBL] [Abstract][Full Text] [Related]
39. Comparative survival analysis in patients with pulmonary metastases from nasopharyngeal carcinoma treated with radiofrequency ablation.
Pan CC; Wu PH; Yu JR; Li W; Huang ZL; Wang JP; Zhao M
Eur J Radiol; 2012 Apr; 81(4):e473-7. PubMed ID: 21700408
[TBL] [Abstract][Full Text] [Related]
40. Percutaneous radiofrequency ablation for unresectable pulmonary metastases from renal cell carcinoma.
Soga N; Yamakado K; Gohara H; Takaki H; Hiraki T; Yamada T; Arima K; Takeda K; Kanazawa S; Sugimura Y
BJU Int; 2009 Sep; 104(6):790-4. PubMed ID: 19338555
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
